サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1635928

豚用ヘルスケア市場レポート：製品別、疾患別、投与経路別、流通チャネル別、地域別、2025-2033年

Swine Healthcare Market Report by Product, Disease, Route of Administration, Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 134 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
豚用ヘルスケア市場レポート：製品別、疾患別、投与経路別、流通チャネル別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 134 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

豚用ヘルスケア市場の世界市場規模は2024年に32億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに56億米ドルに達し、2025年から2033年にかけて6.15%の成長率（CAGR）を示すと予測しています。豚製品への依存度の増加、商業養豚と輸出活動の大幅な増加、豚伝染病に対する意識の高まりが、市場を牽引する主な要因のいくつかです。

豚用ヘルスケアは、豚の疾病時の不快感を軽減することを目的とした製品、治療手順、診断キットの幅広いカテゴリーを指します。不妊症や先天異常のような一般的な豚関連疾患の治療や、そのような疾患を予防するための治療薬の開発に重点が置かれています。調整された世界の疾病モニタリング、将来の脅威の影響を最小限に抑えるための的を絞った調査投資、データ分析は、豚用ヘルスケア管理の一部です。また、適切な時期にワクチン接種を行い、責任を持って抗生物質を使用することで、豚の疾病に対する免疫力を高めながら、ウイルスや細菌を予防することも重要です。豚へのヘルスケアサービスの提供に加え、豚舎設計、豚の移動、ワクチン接種プロトコル、牛群の健康モニタリング、疾病サーベイランス、状況に応じた診断検査を通じて、疾病リスクの最小化を推進します。

大衆の間で豚肉製品への依存度が高まっていることが、市場の成長を促進する主な要因のひとつです。これは、世界中で商業的養豚と輸出活動が大幅に増加していることに起因しています。これに伴い、豚インフルエンザ、サルモネラ菌、肺炎マイコプラズマ、古典的豚熱（CSF）など、多くの疾病の流行が増加していることも、市場の活性化に拍車をかけています。さらに、豚が媒介する病気に対する意識の高まりが、豚用ヘルスケア製品の普及につながっています。また、豚の健康維持に向けた政府機関の積極的な取り組みも、市場の成長を後押ししています。豚を食べる人口が増え続けていることが、健康な豚家畜の需要を後押ししており、これがさらに市場に弾みをつけています。これに加えて、豚インフルエンザや豚熱を予防し、豚の病気が人間に及ぼす影響を軽減するワクチンの開発に重点を置いた広範な研究開発（R&D）活動が、市場に貢献しています。さらに、動物病院における画像診断の導入が進み、付属品や診断機器の需要が高まっていることも市場に貢献しています。市場の見通しを明るいものにしているその他の要因としては、家畜生産を増加させるためのワクチン、抗生物質、外科治療の採用率の増加、食中毒の発生率の大幅な上昇、急速な世界化、有機豚肉への需要の加速、飲食品（F&B）産業の大幅な成長などがあります。

本レポートで扱う主な質問

  • 世界の豚用ヘルスケア市場の規模は？
  • 2025-2033年における世界の豚用ヘルスケア市場の予想成長率は？
  • 世界の豚用ヘルスケア市場を牽引する主要因は何か？
  • 世界の豚用ヘルスケア市場に対するCOVID-19の影響は？
  • 世界の豚用ヘルスケア市場の製品別内訳は？
  • 世界の豚用ヘルスケア市場の疾患別内訳は？
  • 世界の豚用ヘルスケア市場における主要地域は？
  • 世界の豚用ヘルスケア市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の豚用ヘルスケア市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 診断検査
    • 市場動向
    • 主要セグメント
      • 酵素結合免疫吸着測定法（ELISA）
      • 急速免疫移動（RIM）
      • 寒天ゲル免疫拡散法（AGID）
      • ポリメラーゼ連鎖反応（PCR）
      • 診断画像
      • その他
    • 市場予測
  • 治療
    • 市場動向
    • 主要セグメント
      • ワクチン
      • 寄生虫駆除剤
      • 抗感染薬
      • 飼料添加物
      • その他
    • 市場予測

第7章 市場内訳：疾患別

  • 滲出性皮膚炎
    • 市場動向
    • 市場予測
  • コクシジウム症
    • 市場動向
    • 市場予測
  • 呼吸器疾患
    • 市場動向
    • 市場予測
  • 豚赤痢
    • 市場動向
    • 市場予測
  • 豚パルボウイルス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：投与経路別

  • 注射
    • 市場動向
    • 市場予測
  • 経口
    • 市場動向
    • 市場予測

第9章 市場内訳：流通チャネル別

  • 動物病院
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第11章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boehringer Ingelheim International GmbH
    • Ceva Animal Health Inc.
    • Elanco
    • IDEXX Laboratories Inc.
    • Innovative Diagnostic
    • Merck & Co. Inc.
    • Phibro Animal Health Corporation
    • Vetoquinol
    • Virbac Corporation
    • Zoetis Inc.
図表

List of Figures

  • Figure 1: Global: Swine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Swine Healthcare Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Swine Healthcare Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Swine Healthcare Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Swine Healthcare Market: Breakup by Disease (in %), 2024
  • Figure 6: Global: Swine Healthcare Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Swine Healthcare Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Swine Healthcare Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Swine Healthcare (Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Swine Healthcare (Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Swine Healthcare (Therapeutics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Swine Healthcare (Therapeutics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Swine Healthcare (Exudative Dermatitis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Swine Healthcare (Exudative Dermatitis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Swine Healthcare (Coccidiosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Swine Healthcare (Coccidiosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Swine Healthcare (Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Swine Healthcare (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Swine Healthcare (Swine Dysentery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Swine Healthcare (Swine Dysentery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Swine Healthcare (Porcine Parvovirus) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Swine Healthcare (Porcine Parvovirus) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Swine Healthcare (Other Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Swine Healthcare (Other Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Swine Healthcare (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Swine Healthcare (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Swine Healthcare (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Swine Healthcare (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Swine Healthcare (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Swine Healthcare (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Swine Healthcare (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Swine Healthcare (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Swine Healthcare (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Swine Healthcare (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Swine Healthcare Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Swine Healthcare Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Swine Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Swine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Swine Healthcare Industry: Value Chain Analysis
  • Figure 86: Global: Swine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Swine Healthcare Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Swine Healthcare Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Swine Healthcare Market Forecast: Breakup by Disease (in Million USD), 2025-2033
  • Table 4: Global: Swine Healthcare Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Swine Healthcare Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Swine Healthcare Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Swine Healthcare Market: Competitive Structure
  • Table 8: Global: Swine Healthcare Market: Key Players
目次
Product Code: SR112025A6654

The global swine healthcare market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.15% during 2025-2033. The increasing dependency on swine products, a considerable rise in commercial swine farming and export activities, and the growing awareness regarding pork-transmitted diseases represent some of the key factors driving the market.

Swine healthcare refers to a broad category of products, treatment procedures, and diagnostic kits that aim to alleviate discomfort during swine diseases. It focuses on treatments for common pig-related disorders like infertility and congenital anomalies as well as the development of therapeutics to prevent such diseases. Coordinated global disease monitoring, targeted research investments that minimize future threat effects, and data analysis are part of swine healthcare management. Along with this, it involves the prevention of viruses and bacteria while enhancing herd disease immunity with appropriately timed vaccinations and responsible antibiotic use. In addition to providing health services to pigs, the swine healthcare system promotes minimizing disease risks through barn design, pig movement, vaccination protocols, herd health monitoring, disease surveillance, and diagnostic tests that are appropriate for the situation.

The increasing dependency on swine products among the masses is one of the key factors driving the growth of the market. This can be attributed to a considerable rise in commercial swine farming and export activities across the globe. In line with this, the rising prevalence of numerous diseases, including swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF), is fueling the market. Moreover, the augmenting awareness regarding pork-transmitted diseases is resulting in a higher uptake of swine healthcare products. Also, favorable initiatives taken by government bodies toward swine health maintenance are fueling the market growth. The continuously growing pork-eating population is propelling the demand for healthy swine livestock, which is further providing an impetus to the market. Besides this, extensive research and development (R&D) activities with an enhanced focus on the development of vaccines to prevent swine flu and swine fever and reduce the effects of swine diseases on humans are contributing to the market. Additionally, the augmenting incorporation of diagnostic imaging in veterinary hospitals leading to an escalating demand for accessories and diagnostic equipment is contributing to the market. Some of the other factors creating a positive market outlook include the growing adoption rates of vaccines, antibiotics, and surgical treatments for increasing livestock production, a significant rise in the rates of foodborne diseases, rapid globalization, the accelerating demand for organic pork, and considerable growth in the food and beverage (F&B) industry.

Key Market Segmentation:

Product Insights:

  • Diagnostic Tests
  • Enzyme Linked Immuno-Sorbent Assay (ELISA)
  • Rapid Immuno Migration (RIM)
  • Agar Gel Immuno-Diffusion (AGID)
  • Polymerase Chain Reaction (PCR)
  • Diagnostic Imaging
  • Others
  • Therapeutics
  • Vaccines
  • Parasiticides
  • Anti-infectives
  • Feed Additives
  • Others
  • The report has also provided a detailed breakup and analysis of the swine healthcare market based on the product. This includes diagnostic tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and others) and therapeutics (vaccines, parasiticides, anti-infectives, feed additives, and others). According to the report, therapeutics represented the largest segment.

Disease Insights:

  • Exudative Dermatitis
  • Coccidiosis
  • Respiratory Diseases
  • Swine Dysentery
  • Porcine Parvovirus
  • Others

Route of Administration Insights:

  • Injectable
  • Oral

Distribution Channel Insights:

  • Veterinary Hospitals
  • Retail Pharmacy
  • Online Pharmacy

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for swine healthcare. Some of the factors driving the North America swine healthcare market included the growing consumption of pork, improving animal healthcare infrastructure, the growing consciousness regarding pork-transmitted diseases, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global swine healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., Elanco, IDEXX Laboratories Inc., Innovative Diagnostic, Merck & Co. Inc., Phibro Animal Health Corporation, Vetoquinol, Virbac Corporation, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global swine healthcare market?
  • 2. What is the expected growth rate of the global swine healthcare market during 2025-2033?
  • 3. What are the key factors driving the global swine healthcare market?
  • 4. What has been the impact of COVID-19 on the global swine healthcare market?
  • 5. What is the breakup of the global swine healthcare market based on the product?
  • 6. What is the breakup of the global swine healthcare market based on the disease?
  • 7. What are the key regions in the global swine healthcare market?
  • 8. Who are the key players/companies in the global swine healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Swine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Diagnostic Tests
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
      • 6.1.2.2 Rapid Immuno Migration (RIM)
      • 6.1.2.3 Agar Gel Immuno-Diffusion (AGID)
      • 6.1.2.4 Polymerase Chain Reaction (PCR)
      • 6.1.2.5 Diagnostic Imaging
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Vaccines
      • 6.2.2.2 Parasiticides
      • 6.2.2.3 Anti-infectives
      • 6.2.2.4 Feed Additives
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Disease

  • 7.1 Exudative Dermatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Coccidiosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Respiratory Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Swine Dysentery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Porcine Parvovirus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Animal Health Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 IDEXX Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Innovative Diagnostic
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Phibro Animal Health Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Vetoquinol
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Virbac Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Zoetis Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report